tetano
Editor, Senior Moderator
Chronic Dis Transl Med. 2020 Mar 27. doi: 10.1016/j.cdtm.2020.02.003. [Epub ahead of print]
Recommended prophylactic and management strategies for severe acute respiratory syndrome coronavirus 2 infection in transplant recipients.
Ju CR[SUP]1[/SUP], Lian QY[SUP]1[/SUP], Zhang JH[SUP]1[/SUP], Qiu T[SUP]2[/SUP], Cai ZT[SUP]2[/SUP], Jiang WY[SUP]3[/SUP], Zhang J[SUP]4[/SUP], Cheng Q[SUP]5[/SUP], Chen G[SUP]6[/SUP], Li N[SUP]7[/SUP], Wang CY[SUP]8[/SUP], He JX[SUP]1[/SUP].
Author information
Abstract
Since December 2019, increasing attention has been paid to the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) epidemic in Wuhan, China. SARS-CoV-2 primarily invades the respiratory tract and lungs, leading to pneumonia and other systemic disorders. The effect of SARS-CoV-2 in transplant recipients has raised significant concerns, especially because there is a large population of transplant recipients in China. Based on the current epidemic situation, this study reviewed publications on this virus and coronavirus disease 2019 (COVID-19), analyzed common features of respiratory viral pneumonias, and presented the currently reported clinical characteristics of COVID-19 in transplant recipients to improve strategies regarding the diagnosis and treatment of COVID-19 in this special population.
? 2020 Chinese Medical Association. Production and hosting by Elsevier B.V. on behalf of KeAi Communications Co., Ltd.
KEYWORDS:
Corona virus disease 2019; Novel coronavirus; Pneumonia; Recipients; Transplantation
PMID:32363045PMCID:PMC7194659DOI:10.1016/j.cdtm.2020.02.003
Free full text
Recommended prophylactic and management strategies for severe acute respiratory syndrome coronavirus 2 infection in transplant recipients.
Ju CR[SUP]1[/SUP], Lian QY[SUP]1[/SUP], Zhang JH[SUP]1[/SUP], Qiu T[SUP]2[/SUP], Cai ZT[SUP]2[/SUP], Jiang WY[SUP]3[/SUP], Zhang J[SUP]4[/SUP], Cheng Q[SUP]5[/SUP], Chen G[SUP]6[/SUP], Li N[SUP]7[/SUP], Wang CY[SUP]8[/SUP], He JX[SUP]1[/SUP].
Author information
Abstract
Since December 2019, increasing attention has been paid to the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) epidemic in Wuhan, China. SARS-CoV-2 primarily invades the respiratory tract and lungs, leading to pneumonia and other systemic disorders. The effect of SARS-CoV-2 in transplant recipients has raised significant concerns, especially because there is a large population of transplant recipients in China. Based on the current epidemic situation, this study reviewed publications on this virus and coronavirus disease 2019 (COVID-19), analyzed common features of respiratory viral pneumonias, and presented the currently reported clinical characteristics of COVID-19 in transplant recipients to improve strategies regarding the diagnosis and treatment of COVID-19 in this special population.
? 2020 Chinese Medical Association. Production and hosting by Elsevier B.V. on behalf of KeAi Communications Co., Ltd.
KEYWORDS:
Corona virus disease 2019; Novel coronavirus; Pneumonia; Recipients; Transplantation
PMID:32363045PMCID:PMC7194659DOI:10.1016/j.cdtm.2020.02.003
Free full text